Arbaclofen for Fragile X … children. With the sponsorship of startup company Seaside Therapeutics, the approach reached stage III clinical trials …
Symposium examines intersecting biology of neurodegeneration, Down syndrome October 11, 2022 … Paolo, executive director of discovery biology at Denali Therapeutics . He discussed the company’s potential therapy …
Glial and Neuronal Biology of the Aging Brain … in Down syndrome" 3:30-4:00pm: Gilbert Di Paolo , Denali Therapeutics, "Lysosomal Functions of Progranulin and …
Autism symptoms sometimes improve amid fever, so a research team will study how to make that a therapy May 08, 2024
